Correlation Between Artemisome and Triple Point

Can any of the company-specific risk be diversified away by investing in both Artemisome and Triple Point at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artemisome and Triple Point into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Artemisome I and Triple Point Venture, you can compare the effects of market volatilities on Artemisome and Triple Point and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artemisome with a short position of Triple Point. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artemisome and Triple Point.

Diversification Opportunities for Artemisome and Triple Point

-0.14

Correlation Coefficient

Artemisome  Triple Point

Good diversification

The 3 months correlation between Artemisome and Triple is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Artemisome I and Triple Point Venture in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Triple Point Venture and Artemisome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artemisome I are associated (or correlated) with Triple Point. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Triple Point Venture has no effect on the direction of Artemisome i.e., Artemisome and Triple Point go up and down completely randomly.

Pair Corralation between Artemisome and Triple Point

Assuming the 90 days trading horizon Artemisome I is expected to generate 3.9 times more return on investment than Triple Point. However, Artemisome is 3.9 times more volatile than Triple Point Venture. It trades about 0.04 of its potential returns per unit of risk. Triple Point Venture is currently generating about -0.03 per unit of risk. If you would invest  25,282  in Artemisome I on September 30, 2024 and sell it today you would earn a total of  3,368  from holding Artemisome I or generate 13.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Artemisome I  vs.  Triple Point Venture

Artemisome I

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Artemisome I has generated negative risk-adjusted returns adding no value to fund investors. Despite quite persistent forward-looking signals, Artemisome is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Triple Point Venture

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Triple Point Venture are ranked lower than 9 (%) of all funds and portfolios of funds over the last 90 days. In spite of rather sound technical and fundamental indicators, Triple Point is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Artemisome and Triple Point

The main advantage of trading using opposite Artemisome and Triple Point positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artemisome position performs unexpectedly, Triple Point can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Triple Point will offset losses from the drop in Triple Point's long position.

The idea behind Artemisome I and Triple Point Venture pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.